Cargando…
COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
The newly emergent novel coronavirus disease 2019 (COVID-19) outbreak, which is caused by SARS-CoV-2 virus, has posed a serious threat to global public health and caused worldwide social and economic breakdown. Angiotensin-converting enzyme 2 (ACE2) is expressed in human vascular endothelium, respir...
Autores principales: | Amraei, Razie, Rahimi, Nader |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407648/ https://www.ncbi.nlm.nih.gov/pubmed/32660065 http://dx.doi.org/10.3390/cells9071652 |
Ejemplares similares
-
COVID‐19 and renin angiotensin aldosterone system: Pathogenesis and therapy
por: Babajani, Fatemeh, et al.
Publicado: (2021) -
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020) -
NEDD4 regulates ubiquitination and stability of the cell adhesion molecule IGPR-1 via lysosomal pathway
por: Sun, Linzi, et al.
Publicado: (2021) -
COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020) -
Renin–Angiotensin System Implications to COVID-19 Comorbidities
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)